|Bid||0.00 x 4000|
|Ask||0.00 x 3000|
|Day's range||68.21 - 69.84|
|52-week range||56.56 - 70.81|
|Beta (5Y monthly)||0.40|
|PE ratio (TTM)||17.09|
|Earnings date||26 Oct 2021 - 01 Nov 2021|
|Forward dividend & yield||2.84 (4.16%)|
|Ex-dividend date||14 Jun 2021|
|1y target est||74.57|
Stan Bergman, Henry Schein CEO, speaks with Yahoo Finance on submitting a letter to the Congressional subcommittee supporting expanded COVID-19 vaccine distribution.
FOSTER CITY, Calif., August 03, 2021--Gilead Sciences, Inc. (Nasdaq: GILD) today announced a more than $200 million endowment to the Gilead Foundation to further the company's vision of creating a healthier world for all people. The Gilead Foundation, established in 2005, builds on the company’s longstanding commitment to supporting underserved communities around the world. It aims to create impact in the community and society by encouraging a culture of giving, engaging in local communities and
Dr. Susannah Hills, Pediatric Airway Surgeon and Assistant Professor of ENT at Columbia University Medical Center, joins Yahoo Finance to discuss the latest on the coronavirus pandemic.